))
Revolutionizing A1C and Biomarker Testing with the Q-Pad
Manage episode 479593124 series 3662135
Content provided by Justin Eastzer. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Justin Eastzer or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
I sat down the Founder of Qvin to explore a groundbreaking device that uses menstrual blood to monitor biomarkers for conditions like cervical cancer, fertility, thyroid health, STIs, and more. Already making waves, Qvin’s FDA-cleared test for A1C measures average blood glucose over three months using a pad-like device during a menstrual cycle, with results sent to a smartphone app. We dive into how this innovation is transforming early diagnostics, its current use for cervical cancer screening in Southeast Asia, and Dr. Naser’s journey—from developing a molecule to block skin cancer to simulating cycles with a robot named Betty.
Learn more about Qvin (affiliate link)
Learn about Omnipod 5 (today's sponsor)*
T1D Exchange Registry Sign up (US only)
Read our Blog + Join the Newsletter
Support Diabetech on Patreon | Diabetech Community Discord
Follow me here: Instagram | Tik Tok | YouTube | Facebook
DISCLAIMERS: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.
*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.
106 episodes
Share
